1 completed, 1 enrolling by invitation, 1 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Enrolling by invitation 1, Terminated 1 |
Follow ralinepag: new trials by email Literature Review of ralinepag trials Research Report on ralinepag
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects Ralinepag, Placebo - Pulmonary Hypertension, Pulmonary Arterial Hypertension | Phase 3 | Terminated | United Therapeutics | 10 | 2021-01-20 | 2026-07-06 |
| A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension Ralinepag - PAH, Pulmonary Hypertension | Phase 3 | Enrolling by invitation | United Therapeutics | 1000 | 2019-09-23 | 2026-10-06 |
| A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients Ralinepag, Placebo - PAH, Pulmonary Hypertension | Phase 3 | Completed | United Therapeutics | 687 | 2019-01-24 | 2026-06-16 |
Hypertension, Pulmonary (3) · Pulmonary Arterial Hypertension (3) · Cardiovascular Diseases (2) · Connective Tissue Diseases (2) · Familial Primary Pulmonary Hypertension (2) · Hypertension (2) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Vascular Diseases (2)
Argentina (3) · Australia (3) · Austria (3) · Belgium (3) · Brazil (3) · Canada (3) · Germany (3) · Italy (3) · Poland (3) · Spain (3) · United Kingdom (3) · United States (3) · Bulgaria (2) · Chile (2) · China (2)